Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Feb 24, 2012

Mylan North America President Tony Mauro Elected Chairman of GPhA

Feb 23, 2012

Mylan Receives Tentative FDA Approval Under PEPFAR for Pediatric HIV/AIDS Therapy

Feb 21, 2012

Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2011

Feb 21, 2012

Mylan Provides Blueprint for 2012 and Beyond

Feb 21, 2012

Mylan Secures an Additional $300 Million of Committed Financing

Feb 21, 2012

Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year

Feb 17, 2012

Mylan Resolves Defamation Litigation Against Pittsburgh Post-Gazette and Two of Its Reporters

Feb 16, 2012

Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement

Feb 15, 2012

Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty

Feb 14, 2012

Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection

Pagination

First page
Previous page
…
Page 63
Page 64
Page 65
Page 66
Current page 67
Page 68
Page 69
Page 70
Page 71
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.